Suppression of tumor angiogenesis by metformin treatment<i>via</i>a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
Jichang Wang(Shenyang Aerospace University), Peijun Liu(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 107
Related Papers
Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
|Journal of Experimental & Clinical Cancer Research|2019|141
Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells
|Scientific Reports|2017|66
miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells
|Cell Cycle|2017|51
RETRACTED ARTICLE: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth
|Cell Death and Disease|2017|45
Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking
|International Journal of Molecular Medicine|2018|32